Psychopharmacological activity of the active constituents of hashish and some related cannabinoids
- 113 Downloads
The psychopharmacological activity of Δ1-tetrahydrocannabinol, (I); Δ1(6)-tetrahydrocannabinol (4′ hexyl), (II); Δ1(6)-tetrahydrocannabinol, (III); 1-ethoxyhexahydrocannabinol, (IV); 8-ethoxy-iso-hexahydrocannabinol, (V); Δ1(6)-tetrahydrocannabinolic acid Me ester, Isomer I, (VI); Δ1(6)-tetrahydrocannabinolic acid Me ester, Isomer II, (VII); cannabigerol, (VIII); Δ1(6)-tetrahydrocannabinol (3′ hexyl), (IX); cannabichromene, (X); has been examined in a variety of animal species.
Compounds (I) and (III) caused severe motor disturbances and a stuporous state in dogs and ptosis, “tameness” and peculiar postural changes in monkeys. In the latter animal, compound (II) elicited similar effects.
Compounds (I) and (III) after intraperitoneal but not subcutaneous administration, suppressed the gerbil digging activity; reduced the rat conditioned avoidance response and induced a cataleptoid reaction in mice, rats and gerbils. In addition, compound (I) reduced the performance of mice on the rotating-rod. Both compounds, administered subcutaneously, induced a measurable ataxic gait in rats.
Amphetamine reversed the behavioural changes elicited by compounds (I) and (III) in monkeys, as well as the cataleptoid reaction in rats.
None of the other compounds provoked observable changes in any of the species studied.
It is suggested that Rhesus monkeys might serve as a suitable model for assessing the psychopharmacological activity of active cannabinoids.
Key-WordsPsychopharmacology Hashish Cannabinoids Monkeys Amphetamine
Unable to display preview. Download preview PDF.
- Bovet, D., G. L. Gatti, and M. Frank: An automatic device for the study of conditioned escape reactions in the rat. I. A programming and recording method for establishing learning, retention and deconditioning curves. Sci. Repts. Ist. Super. Sanità 1, 127–138 (1961).Google Scholar
- Dunham, N. W., and T. S. Miya: A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Amer. pharm. Ass., sci. Ed. 46, 208 (1957).Google Scholar
- Gaoni, Y., and R. Mechoulam: Isolation, structure and partial synthesis of an active constituent of hashish. J. Amer. chem. Soc. 86, 1646 (1964).Google Scholar
- Garattini, S.: Effects of a cannabis extract on gross behaviour. In: Hashish: its chemistry and pharmacology. CIBA Foundation Study Group No. 21, pp. 70–78. Eds.: G. E. W. Wolstenholme and J. Knight. London: J. & A. Churchill 1965.Google Scholar
- Grunfeld, Y., and H. Edery: Psychopharmacological activity of some substances extracted from Cannabis sativa L. (Hashish). Abst. Proc. Israel Physiol. Pharmacol. Soc. 16th Scient. Meeting, Jerusalem (1968).Google Scholar
- Hively, R. L., W. A. Mosher, and F. W. Hoffmann: Isolation of trans-Δ 6-tetrahydrocannabinol from marijuana. J. Amer. chem. Soc. 88, 1832–1833 (1966).Google Scholar
- Hofmann, A.: Psychotomimetic agents. In: Drugs affecting the central nervous system. Medicinal Research, Vol.2, pp. 169–235. Ed.: A. Burger. New York: Dekker 1968.Google Scholar
- Isbell, H., C. W. Gorodetzsky, D. Jasinski, U. Claussen, F. V. Spulak, and F. Korte: Effects of (−)-Δ9-trans-tetrahydrocannabinol in man. Psychopharmacologia (Berl.) 11, 184–188 (1967).Google Scholar
- Joachimoglu, G.: Natural and smoked hashish. In: Hashish: its chemistry and pharmacology. CIBA Foundation Study Group No. 21, pp. 2–11. Eds.: G. E. W. Wolstenholme and J. Knight. London: J. & A. Churchill 1965.Google Scholar
- Kalir, A., D. Baldermann, H. Edery, and G. Porath: 7-methoxyindole and its derivatives. Israel J. Chem. 5, 129–136 (1967).Google Scholar
- H. Edery, Z. Pelah, D. Balderman, and G. Porath: 1-phenylcycloalkylamine derivatives. Part II. Synthesis and pharmacological activity. J. med. Chem. (in press) (1969).Google Scholar
- Loewe, S.: Pharmacological study. In: The marihuana problem in the city of New York. Mayors Committee on Marihuana, pp. 149–212. Lancaster, Pennsylvania: Jacques Cattell Press 1944.Google Scholar
- —: Studies on the pharmacology and acute toxicity of compounds with marihuana activity. J. Pharmacol. exp. Ther. 88, 154–161 (1946).Google Scholar
- —: Cannabiswirkstoffe und Pharmakologie der Cannabinole. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 211, 175–193 (1950).Google Scholar
- Mechoulam, R., and Y. Gaoni: Recent advances in the chemistry of hashish. Fortschr. Chem. org. Nat.-Stoffe 25, 175–213 (1967).Google Scholar
- —, B. Yagnitinsky, and Y. Gaoni: Stereoelectronic factor in the chloranil dehydrogenation of cannabinoids. Total synthesis of dl-cannabichromene. J. Amer. chem. Soc. 90, 2418–2420 (1968).Google Scholar
- Naftali, J., and J. Wolf: Notes on breeding experiments with the albino strain of meriones tristrami Thomas 1829. Bull. Res. Coun. Israel 5 B, 189–191 (1955).Google Scholar
- Norton, S.: Behavioural patterns as a technique for studying psychotropic drugs. In: Psychotropic drugs, pp. 73–82. Eds.: S. Garattini and V. Ghetti. Amsterdam: Elsevier 1957.Google Scholar
- Porath, G., and H. Edery: Psychopharmacological actions and effects on smooth muscle of some substituted indolealkylamines. Proc. Israel Physiol. Pharmacol. Soc. 1, 9 (1965).Google Scholar
- Rushton, R., H. Steinberg, and C. Tinson: Effects of a single experience on subsequent reactions to drugs. Brit. J. Pharmacol. 20, 90–105 (1963).Google Scholar
- Walton, R. P., L. F. Martin, and J. H. Keller: The relative activity of various purified products obtained from american grown hashish. J. Pharmacol. exp. Ther. 62, 239–251 (1938).Google Scholar
- Wolstenholme, G. E. W., and J. Knight: Hashish: its chemistry and pharmacology. CIBA Foundation Study Group No. 21. London: J. & A. Churchill 1965.Google Scholar